Počet záznamů: 1
Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways
SYS 0557510 LBL 01000a^^22220027750^450 005 20240103230705.2 014 $a 35053339 $2 PUBMED 014 $a 000757973600001 $2 WOS 017 70
$a 10.3390/cells11020223 $2 DOI 100 $a 20220519d m y slo 03 ba 101 0-
$a eng 102 $a CH 200 1-
$a Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways 215 $a 13 s. $c E 463 -1
$1 001 cav_un_epca*0491398 $1 011 $e 2073-4409 $1 200 1 $a Cells $v Roč. 11, č. 2 (2022) $1 205 $a ONLINE $1 210 $c MDPI 608 $a Article 610 $a myelodysplastic syndrome 610 $a Azacytidine 610 $a resistance 610 $a CDX mice 610 $a pi3k 610 $a AKT signaling 700 -1
$3 cav_un_auth*0053092 $a Minařík $b L. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, Gen Fac Hosp, Clin Haematol, Prague 12808, Czech Republic 701 -1
$3 cav_un_auth*0269614 $a Pimková $b K. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0386212 $a Kokavec $b J. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0430755 $a Schaffartzikova $b A. $y CZ $4 070 $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0400636 $a Vellieux $b F. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0430756 $a Kulvait $b V. $y CZ $4 070 $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0360804 $a Daumová $b L. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0430757 $a Dusilkova $b N. $y CZ $4 070 $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, Gen Fac Hosp, Clin Haematol, Prague 12808, Czech Republic, Charles Univ Prague, Med Fac 1, Pathophysiol, Prague 12853, Czech Republic 701 -1
$3 cav_un_auth*0344682 $a Jonasova $b A. $y CZ $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, 701 -1
$3 cav_un_auth*0430758 $a Vargova $b K. $y CZ $4 070 $q Charles Univ Prague, Med Fac 1, Pathophysiol, Prague 12853, Czech Republic, 701 -1
$3 cav_un_auth*0425870 $a Králová Viziová $b Petra $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $q Inst Mol Genet, Czech Ctr Phenogen, Vestec 25250, Czech Republic, $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0241788 $a Sedláček $b Radislav $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $q Inst Mol Genet, Czech Ctr Phenogen, Vestec 25250, Czech Republic, $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0020440 $a Zemanová $b Z. $y CZ $q Gen Fac Hosp, Cytogenet, Prague 12808, Czech Republic, 701 -1
$3 cav_un_auth*0089761 $a Stopka $b T. $y CZ $z K $q Charles Univ Prague, Med Fac 1, BIOCEV, Vestec 25250, Czech Republic, Gen Fac Hosp, Clin Haematol, Prague 12808, Czech Republic 856 $u https://www.mdpi.com/2073-4409/11/2/223 $9 RIV
Počet záznamů: 1